Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants - Health Reporter
Health Reporter,
In a recent study published in Frontiers in Immunology, a team of researchers from the United States developed an affordable…